Pfizer Ltd.

Financial

	Pfizer	Eris Lifesciences	Alembic Pharma
Operational Metrics
Pharmaceutical Sector
Domestic Sales Growth - YoY	4.7 %	9.3 %	n/a
Financials
5 yr Average ROE	18.39 %	19.85 %	15.79 %
5yr average Equity Multiplier	1.28	1.5	1.48
5yr Average Asset Turnover Ratio	0.6	0.58	0.83
5yr Avg Net Profit Margin	24.04 %	25.85 %	13.0 %
Price to Book	5.18	7.23	3.55
P/E	31.54	60.83	28.71
5yr Avg Cash Conversion Cycle	-2.02 Days	-99.43 Days	1.45 Days
Inventory Days	49.44 Days	26.22 Days	94.67 Days
Days Receivable	26.74 Days	61.69 Days	60.69 Days
Days Payable	81.1 Days	164.23 Days	176.63 Days
5yr Average Interest Coverage Ratio	170.95	94.87	36.16
5yr Avg ROCE	23.56 %	21.14 %	17.34 %
5yr Avg Operating Profit Margin	30.56 %	34.25 %	19.56 %
5 yr average Debt to Equity	0.0	0.29	0.2
5yr CAGR Net Profit	65.36 %	5.74 %	-5.77 %
5yr Average Return on Assets	14.39 %	15.49 %	10.48 %
Shareholdings
Promoter Holding	63.92 %	54.85 %	69.67 %
Share Pledged by Promoters	0.0	18.51 %	0.0
Change in Promoter Holding (3 Yrs)	0.0	2.19 %	0.06 %
Change in Mutual Fund Holding (3 Yrs)	3.65 %	6.48 %	4.02 %

Business

	Pfizer	Eris Lifesciences	Alembic Pharma
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Pharmaceuticals 0 Formulations 0 API 0	Product Wise Break-Up Pharmaceutical 0 Pharmaceutical 100.0 API 0 Formulations 0	Product Wise Break-Up Pharmaceutical 0 Pharmaceuticals 0 Active Pharmaceutical Ingredient (API) 15.3 Formulations 84.7
Location Wise Break-Up	Location Wise Break-Up India 96.14 Rest of the World 3.86 West India 0 East India 0 South India 0 North India 0	Location Wise Break-Up South India 35.0 West India 30.0 India 0 North India 16.0 East India 15.0 Rest of the World 0 Others 4.0	Location Wise Break-Up South India 0 West India 0 India 39.88 North India 0 East India 0 Rest of the World 60.12